Search results
Results From The WOW.Com Content Network
A micrograph showing yolk sac tumour, with smooth external surface and capsule tears [citation needed] The ovarian yolk sac tumors, also known as endodermal sinus tumors, are accountable for approximately 15.5% of all OGCTs. [8] They have been observed in women particularly in their early ages, and rarely after 40 years of age. [9]
Histologically, yolk sac tumors are characterized by the presence of Schiller-Duval bodies (which are pathognomonic for yolk sac tumors) and a reticular pattern. Yolk sac tumors commonly secrete alpha-fetoprotein and can be immunohistochemically stained for its presence; the level of alpha-fetoprotein in the blood is a useful marker of ...
A dysgerminoma is a type of germ cell tumor; [1] it usually is malignant and usually occurs in the ovary.. A tumor of the identical histology but not occurring in the ovary may be described by an alternate name: seminoma in the testis [2] or germinoma in the central nervous system or other parts of the body.
The 1997 International Germ Cell Consensus Classification [17] is a tool for estimating the risk of relapse after treatment of malignant germ-cell tumor. A small study of ovarian tumors in girls [18] reports a correlation between cystic and benign tumors, and conversely, solid and malignant tumors. Because the cystic extent of a tumor can be ...
Tumor of the ovary vary remarkably as they may arise from any of the 3 cell types of the normal ovary. Ovarian tumors are classified according to the histology of the tumor, obtained in a pathology report. Histology dictates many aspects of clinical treatment, management, and prognosis. The most common forms are:
Ovarian germ cell tumors: Benign [39] Dysgerminoma: Typically occurs in young women between the ages of 10–30 years of age [40] Choriocarcinoma: Can occur without gynecological symptoms [41] Yolk sac tumor: Malignant. Occurs in young children [42] Teratoma: Very rare. Often occurs in newborns [medical citation needed] Ovarian serous ...
An important key to distinguish it from other tumors, such as seminoma (vacuolated), teratocarcinoma (three differentiated germ layers), yolk sac tumor (Schiller–Duval bodies), and the Sertoli–Leydig cell tumor (strings of glands), is that the embryonal carcinoma cells are "trying" to evolve into their next stage of development.
Of special concern is the secretion of alpha-fetoprotein (AFP); under some circumstances, AFP can be used as a diagnostic marker specific for the presence of yolk sac cells within the teratoma. These cells can develop into a frankly malignant tumor known as yolk sac tumor or endodermal sinus tumor.